Skip to content

Cerus CERS Accrued Liabilities, Current

Accrued Liabilities, Current at other companies

CorMedix logo
CorMedixCRMD

Other financials

Income statement

See full
Revenue$53.7M+24.1%
Operating income-$354.0K+94.0%
Net income-$1.6M+78.7%
EPS (diluted)-$0.01+75.0%

Balance sheet

See full
Cash & equivalents$27.9M+43.0%
Total debt$45.0M-43.3%
Total equity$67.6M+21.7%
Total assets$222.9M+7.8%

Cash flow

See full
Operating cash flow-$3.0M-261%
CapEx$233.0K+108%
Free cash flow-$3.3M-243%

Valuation

See full
Market cap$573.06M+124%
Enterprise value$590.17M+86.7%
P/S2.9×-1.0×

Profitability

See full
Gross margin64%
Operating margin-6.2%-2.1pp
Net margin-9.8%-2.8pp
FCF margin3.5%+1.9pp

Returns & leverage

See full
Return on equity-15.5%-5.6pp
Debt / equity0.7×-0.8×
Current ratio1.6×-0.7×

Where this comes from

Reported directly by Cerus in its filing.

Tagged under the XBRL concept us-gaap:AccruedLiabilitiesCurrent.

The official record: Cerus’s 10-Q, filed April 30, 2026, on SEC EDGAR. View the filing →

Ask your AI about Cerus's accrued liabilities, current.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Cerus's accrued liabilities, current?
Cerus (CERS) reported accrued liabilities, current of $18.33M in Q1 2026.
How has Cerus's accrued liabilities, current changed year-over-year?
Cerus's accrued liabilities, current increased by 8.2% year-over-year, from $16.94M to $18.33M.
What is the long-term trend for Cerus's accrued liabilities, current?
Over 5 years (2020 to 2025), Cerus's accrued liabilities, current has grown at a 0.4% compound annual growth rate (CAGR), from $24.75M to $25.27M.